Location History:
- Chiba, JP (1992)
- Tokyo, JP (1996 - 2009)
Company Filing History:
2 out of 12 
1 out of 417 
1 out of 151 
Years Active: 1992-2009
Certainly! Here is the article about inventor Sueharu Horinouchi:
Title:
Exploring the Innovations of Sueharu Horinouchi
Introduction:
Sueharu Horinouchi, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with his inventive breakthroughs. With an impressive portfolio of 9 patents, he continues to pave the way for advancements in medical treatments.
Latest Patents:
1. **Histone deacetylase inhibitors and methods for producing the same:** Sueharu Horinouchi's latest patent showcases compounds with potent inhibitory activity specific to HDAC1 and HDAC4. These compounds hold great promise as pharmaceutical agents for combating diseases associated with these histone deacetylases.
2. **Reduced FK228 and use thereof:** His invention of reduced FK228 and its derivatives as histone deacetylase inhibitors has opened new avenues for gene therapy and disease treatment. These compounds demonstrate strong inhibitory properties, presenting a novel approach in the medical field.
Career Highlights:
Throughout his career, Sueharu Horinouchi has been associated with renowned companies such as Bio-polymer Research Co., Ltd. and Astellas Pharma GmbH. His expertise and dedication have played a crucial role in shaping the pharmaceutical landscape, garnering recognition for his innovative contributions.
Collaborations:
Working alongside esteemed colleagues like Minoru Yoshida and Teruhiko Beppu, Sueharu Horinouchi has fostered a collaborative environment conducive to groundbreaking discoveries. These partnerships have led to the development of groundbreaking solutions that address pressing medical challenges.
Conclusion:
In conclusion, Sueharu Horinouchi stands as a beacon of innovation in the realm of pharmaceutical inventions. His prolific career, marked by revolutionary patents and fruitful collaborations, underscores his commitment to driving progress in healthcare. As he continues to push boundaries and redefine possibilities, the future holds great promise for his impactful contributions.